Product Information
DOXYCYCLINE MONO 150 MG TABLET is a generic product labeled by Lannett Company Inc., priced at $0.9520 per EA under NDC 00527153730. Its NADAC has been published 222 times since Nov 28, 2013.
Strength
150 mg/1
Manufacturer
Lannett Company Inc.NDC
00527153730
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
10/23/2024
Active Ingredients
DOXYCYCLINEApproval Type
Generic (ANDA)
FDA Application
ANDA065285On Market Since
8/25/2008
Pharmacological Classes
Price Statistics
The NADAC for DOXYCYCLINE MONO 150 MG TABLET has been published 222 times since Nov 28, 2013, and over the history we have for it it has declined 80.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9520 per EA |
|---|---|
| All-time high | $6.8363 (Feb 12, 2014) |
| All-time low | $0.8310 (Aug 21, 2024) |
| Median price | $4.7305 |
| Average price | $4.3662 |
| Largest weekly change | -79.0% (Apr 17, 2024) |
| Weeks tracked | 222 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DOXYCYCLINE MONO 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE MONO 150 MG TABLET, manufactured by Lannett Company Inc., is $0.9520 per EA (NDC 00527153730), effective Nov 13, 2024.
How has the price of DOXYCYCLINE MONO 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for DOXYCYCLINE MONO 150 MG TABLET has declined 80.0%. It has been tracked across 222 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DOXYCYCLINE MONO 150 MG TABLET?
Since Nov 28, 2013, the NADAC for DOXYCYCLINE MONO 150 MG TABLET has ranged from a low of $0.8310 (Aug 21, 2024) to a high of $6.8363 (Feb 12, 2014), with a median of $4.7305 per EA.
Are there cheaper alternatives to DOXYCYCLINE MONO 150 MG TABLET?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DOXYCYCLINE MONO 150 MG TABLET, is $0.6952 per EA — about 27% below DOXYCYCLINE MONO 150 MG TABLET.
Who manufactures DOXYCYCLINE MONO 150 MG TABLET?
DOXYCYCLINE MONO 150 MG TABLET (NDC 00527153730) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification